Therefore, when pursuing a curative treatment for DOCK8 deficiency it is imperative that several modalities are explored at the developmental stage to maximize the therapeutic effects while considering disease mechanism, mutation locations, and strategies for delivery and correction. This evidence concerns the gene DOCK8 and hyperinsulinemic hypoglycemia, familial, 4.